| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5623704 | Alzheimer's & Dementia | 2017 | 11 Pages |
Abstract
ADNI-3 will aim to inform AD treatment trials and facilitate development of AD disease-modifying treatments.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Michael W. Weiner, Dallas P. Veitch, Paul S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Robert C. Green, Danielle Harvey, Clifford R. Jr., William Jagust, John C. Morris, Ronald C. Petersen, Jennifer Salazar, Andrew J. Saykin, Leslie M. Shaw,